Teva Pharmaceuticals
TEVA
TEVA
436 hedge funds and large institutions have $4.81B invested in Teva Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 138 increasing their positions, 117 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
0.53% less ownership
Funds ownership: 47.17% → 46.64% (-0.53%)
3% less funds holding
Funds holding: 448 → 436 (-12)
13% less first-time investments, than exits
New positions opened: 46 | Existing positions closed: 53
Holders
436
Holding in Top 10
6
Calls
$383M
Puts
$377M
Top Buyers
| 1 | +$82.2M | |
| 2 | +$17.3M | |
| 3 | +$17.2M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$16.8M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$15.8M |
Top Sellers
| 1 | -$93.9M | |
| 2 | -$48.8M | |
| 3 | -$22.8M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$17.7M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$15.2M |